ConductScience.org, home

Paper42018115

Branch retinal vein occlusion in Leber hereditary optic neuropathy with onset at age 50 years or older: frequency and clinical characteristics.

Takai Y and 4 others. Jpn J Ophthalmol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Branch retinal vein occlusion in Leber hereditary optic neuropathy with onset at age 50 years or older: frequency and clinical characteristics. Papers, record 42018115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42018115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Branch retinal vein occlusion in Leber hereditary optic neuropathy with onset at age 50 years or older: frequency and clinical characteristics.
PubMed
Journal
Jpn J Ophthalmol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Observational Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takai YYasuyukihttps://orcid.org/0000-0001-7971-8258
2Yamagami AAkiko
3Inoue KKenji
4Ishikawa HHitoshi
5Wakakura MMasato

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Retinal Vein OcclusionMajor topic
Optic Atrophy, Hereditary, LeberMajor topic
Visual AcuityMajor topic
Humans
Male
Female
Retrospective Studies
Middle Aged
Aged
Fluorescein Angiography
Prevalence
Tomography, Optical Coherence
Age of Onset
Fundus Oculi
Follow-Up Studies
Japan
Laser Coagulation

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139188832Systemic Risk Factors in Branch Retinal Vein Occlusion: a Comprehensive Review.Maedica (Bucur)2024https://conductscience.org/library/papers/39188832PubMed
229790285Peripapillary vessel density changes in Leber's hereditary optic neuropathy: a new biomarker.Clin Exp Ophthalmol2018https://conductscience.org/library/papers/29790285PubMed
319525327Gene-environment interactions in Leber hereditary optic neuropathy.Brain2009https://conductscience.org/library/papers/19525327PubMed
434247170Changes in Retinal Perfusion in Leber's Hereditary Optic Neuropathy: An Optical Coherence Tomography-Angiography Study.Ophthalmic Res2021https://conductscience.org/library/papers/34247170PubMed
528892826Increased Mortality and Comorbidity Associated With Leber's Hereditary Optic Neuropathy: A Nationwide Cohort Study.Invest Ophthalmol Vis Sci2017https://conductscience.org/library/papers/28892826PubMed
640051721Leber's Hereditary Optic Neuropathy with Retinal Hemorrhage.Neuroophthalmology2025https://conductscience.org/library/papers/40051721PubMed
721174521Central retinal vein occlusion as the initial manifestation of LHON / MELAS overlap syndrome with mitochondrial DNA G13513A mutation--case report and literature review.Ophthalmic Genet2011https://conductscience.org/library/papers/21174521PubMed
828650878Leber hereditary optic neuropathy: bridging the translational gap.Curr Opin Ophthalmol2017https://conductscience.org/library/papers/28650878PubMed
926751637Retinal Vein Occlusion in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Disease Study.Ophthalmic Epidemiol2016https://conductscience.org/library/papers/26751637PubMed
1021970465Endothelial dysfunction and increased oxidative stress in mitochondrial diseases.Clin Sci (Lond)2012https://conductscience.org/library/papers/21970465PubMed
1111190017The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.Trans Am Ophthalmol Soc2000https://conductscience.org/library/papers/11190017PubMed
1236605901Mitochondrial dysfunction in vascular endothelial cells and its role in atherosclerosis.Front Physiol2022https://conductscience.org/library/papers/36605901PubMed
1321112411Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Prog Retin Eye Res2011https://conductscience.org/library/papers/21112411PubMed
146743093Fundus findings in Leber's hereditary optic neuroretinopathy. III. Fluorescein angiographic studies.Arch Ophthalmol1984https://conductscience.org/library/papers/6743093PubMed
1528386476New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion.J Ophthalmol2017https://conductscience.org/library/papers/28386476PubMed
1640499779Nitric Oxide May Adversely Affect the Metabolism and Viability of Retinal Organoids Derived from Patients with Leber Hereditary Optic Neuropathy.Am J Pathol2025https://conductscience.org/library/papers/40499779PubMed
1720071683Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study.Invest Ophthalmol Vis Sci2010https://conductscience.org/library/papers/20071683PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42018115

GET https://conductscience.org/api/papers/v1/42018115/authors